Bio-IT World November 30, 2022
An artificial intelligence-based framework that assesses the effectiveness of novel cancer therapies in real time; three new AI-rare disease partnerships; a cross-border federated network of national genome collections for biomedical research and personalized medicine solutions; multi-scale precision cardiology platforms and heart-on-a-chip technology aimed at developing the infrastructure for a digital replica of an individual’s heart; and more.
Genomenon has announced a partnership with COMBINEDBrain, SynGAP Research Fund, and SLC6A1 Connect, three rare disease research foundations focusing on severe rare neurodevelopmental disorders and the rare genetic diseases caused by variation in SYNGAP1 and SLC6A1, respectively. Genomenon will collaborate with the foundations and their pharma partners, delivering comprehensive genomic data on their diseases of focus with the goal...
Today's Sponsors
Today's Sponsor